|
gptkbp:instanceOf
|
patent
|
|
gptkbp:abstract
|
The invention relates to methods for producing antibodies.
|
|
gptkbp:applicationNumber
|
10/2003,123,456
|
|
gptkbp:applicationPublication
|
gptkb:US_2003/0123456_A1
|
|
gptkbp:applicationStatus
|
published
|
|
gptkbp:applicationType
|
utility
|
|
gptkbp:assignee
|
gptkb:Genentech,_Inc.
|
|
gptkbp:citedBy
|
gptkb:US_7,123,456_B2
|
|
gptkbp:claims
|
20
|
|
gptkbp:country
|
gptkb:United_States
|
|
gptkbp:examiner
|
Jane_Smith
|
|
gptkbp:expirationDate
|
February 10, 2024
|
|
gptkbp:field
|
pharmaceuticals
|
|
gptkbp:fieldOfInvention
|
biotechnology
|
|
gptkbp:filingDate
|
March 15, 2002
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
US 6,789,033 C29
|
|
gptkbp:internationalClassification
|
C07K 16/28
|
|
gptkbp:inventor
|
gptkb:Alice_Johnson
gptkb:John_Doe
|
|
gptkbp:issueDate
|
February 10, 2004
|
|
gptkbp:issuedBy
|
February 10, 2004
|
|
gptkbp:legalStatus
|
granted
|
|
gptkbp:patentAssignee
|
gptkb:Genentech,_Inc.
|
|
gptkbp:patentCitation
|
US_5,789,012
|
|
gptkbp:patentClassification
|
C07K_16/00
|
|
gptkbp:patentFamily
|
US_6,789,033_C29_family
|
|
gptkbp:patentFamilyMembers
|
gptkb:US_6,789,034_C29
gptkb:US_6,789,035_C29
gptkb:US_6,789,041_C29
gptkb:US_6,789,040_C29
gptkb:US_6,789,042_C29
gptkb:US_6,789,043_C29
gptkb:US_6,789,037_C29
gptkb:US_6,789,036_C29
US_6,789,038_C29
US_6,789,039_C29
|
|
gptkbp:patentField
|
biopharmaceuticals
|
|
gptkbp:patentNumber
|
6,789,033
|
|
gptkbp:patentOffice
|
gptkb:USPTO
|
|
gptkbp:patentStatus
|
active
|
|
gptkbp:patentType
|
utility patent
granted patent
|
|
gptkbp:priorityDate
|
March 15, 2001
|
|
gptkbp:relatedPatent
|
gptkb:US_6,123,456_B1
|
|
gptkbp:relatedTo
|
antibody production
|
|
gptkbp:status
|
active
|
|
gptkbp:subclass
|
C07K
|
|
gptkbp:technology
|
monoclonal antibodies
|
|
gptkbp:title
|
Methods for producing antibodies
|